Effects of LY267108, an erythromycin analogue derivative, on lower esophageal sphincter function in the cat.
OBJECTIVE
Erythromycin (EM-A) and some of its analogues stimulate gastrointestinal smooth muscle contractions. Because gastroesophageal reflux disease (GERD) in humans is in part caused by a reduction in lower esophageal sphincter (LES) pressure, the aim of this study was to investigate the effect of LY267108 (an EM-A analogue with no significant antimicrobial activity) on LES function.


METHODS
In ketamine-anesthetized cats, LES pressure was recorded using a Dent sleeve.


RESULTS
In cats, LY267108 increased LES pressure, as did motilin and EM-A. Neither LY267108, EM-A, nor motilin altered LES relaxation in response to a swallow. LY267108 increased LES pressure in cats in which the basal LES pressure was lowered experimentally by perfusing the distal esophagus with HCl (0.1 N for 3 days) or following isoproterenol (3.0 micrograms/kg intravenously). In summary, LY267108 increases LES pressure in normal cats, did not affect the relaxation of the LES in response to a swallow, and increases LES pressure in animals with an experimentally induced decrease in LES pressure.


CONCLUSIONS
The results suggest that LY267108 may be useful in treating GERD because of its ability to increase LES pressure and thus present a barrier for gastroesophageal reflux.
Greenwood
B
B
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Dieckman
D
D
Kirst
H A
HA
Gidda
J S
JS
D000818:Animals; D002415:Cats; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D004941:Esophagitis / Q000503:physiopathology; D004943:Esophagogastric Junction / Q000187:drug effects* / Q000502:physiology; D005260:Female; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D011312:Pressure; D012016:Reference Values
C086071:LY 267108; D004917:Erythromycin; D007545:Isoproterenol